ATC code P02 Anthelmintics is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup P02 is part of the anatomical group P Antiparasitic products, insecticides and repellents.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
P02B Antitrematodals
P02BA Quinoline derivatives and related substances
P02BA01 Praziquantel P02BA02 Oxamniquine P02BA03 ArpraziquantelP02BB Organophosphorous compounds
P02BB01 MetrifonateP02BX Other antitrematodal agents
P02BX01 Bithionol P02BX02 Niridazole P02BX03 Stibophen P02BX04 TriclabendazoleP02C Antinematodal agents
P02CA Benzimidazole derivatives
P02CA01 Mebendazole P02CA02 Tiabendazole P02CA03 Albendazole P02CA04 Ciclobendazole P02CA05 Flubendazole P02CA06 Fenbendazole P02CA51 Mebendazole, combinationsP02CB Piperazine and derivatives
P02CB01 Piperazine P02CB02 DiethylcarbamazineP02CC Tetrahydropyrimidine derivatives
P02CC01 Pyrantel P02CC02 OxantelP02CE Imidazothiazole derivatives
P02CE01 LevamisoleP02CF Avermectines
P02CF01 IvermectinP02CX Other antinematodals
P02CX01 Pyrvinium P02CX02 Bephenium P02CX03 MoxidectinP02D Anticestodals
P02DA Salicylic acid derivatives
P02DA01 NiclosamideP02DX Other anticestodals
P02DX01 Desaspidin P02DX02 DichlorophenReferences
"ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020. https://www.nlm.nih.gov/research/umls/sourcereleasedocs/current/ATC/index.html ↩
World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022. /wiki/World_Health_Organization ↩
"Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022. https://www.whocc.no/atc/structure_and_principles/ ↩
"ATC/DDD Index 2022: code P02". WHO Collaborating Centre for Drug Statistics Methodology. http://www.whocc.no/atc_ddd_index/?code=P02 ↩